Sionna Therapeutics, Inc.
SION
$12.14
-$0.46-3.65%
NASDAQ
| 12/31/2024 | 12/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.88M | 2.71M | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.13M | 12.60M | |||
| Operating Income | -18.13M | -12.60M | |||
| Income Before Tax | -15.85M | -11.88M | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -15.85M | -11.88M | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.85M | -11.88M | |||
| EBIT | -18.13M | -12.60M | |||
| EBITDA | -17.97M | -12.43M | |||
| EPS Basic | -3.38 | -3.92 | |||
| Normalized Basic EPS | -2.11 | -2.45 | |||
| EPS Diluted | -3.38 | -3.92 | |||
| Normalized Diluted EPS | -2.11 | -2.45 | |||
| Average Basic Shares Outstanding | 4.69M | 3.03M | |||
| Average Diluted Shares Outstanding | 4.69M | 3.03M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||